LJPC - La Jolla Pharmaceutical Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue10,056-6161,057
Cost of Revenue116,54584,57562,28829,092
Gross Profit-106,489-84,575-61,672-28,035
Operating Expenses
Research Development----
Selling General and Administrative82,76230,85216,70013,934
Non Recurring----
Others----
Total Operating Expenses199,307115,42778,98843,026
Operating Income or Loss-189,251-115,427-78,372-41,969
Income from Continuing Operations
Total Other Income/Expenses Net-10,21862418757
Earnings Before Interest and Taxes-189,251-115,427-78,372-41,969
Interest Expense-7,303-7,303-7,303-7,303
Income Before Tax-199,469-114,803-78,185-41,912
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-199,469-114,803-78,185-41,912
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-199,469-114,803-78,185-41,912
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-199,469-114,803-78,185-41,912